North America
Genetic Technologies to Raise A$5M in Direct Stock Offering
The firm said several institutional investors had inked definitive agreements for the purchase and sale of 3,846,155 American Depositary Shares.
Through its OEM partner, the company secured NMPA registrations for IVD use in China for its bone marrow aspirate DNA exaction kit and its DNA staining reagents.
MDxHealth Prices $40M Public Offering
The diagnostics company is offering 10 million American Depositary Shares at $4.00 per share, with an option to underwriters to buy another 1.5 million.
In Brief This Week: Meridian Bioscience, BARDA, HHS, Oncocyte, GeneDx, More
News items for the week of Jan. 30, 2023.
Becton Dickinson Fiscal Q1 Revenues Down 3 Percent; Firm Raises FY23 Guidance
The Franklin Lakes, New Jersey-based firm saw a 17 percent decline in its life sciences business due to an expected drop in COVID-19 testing.
Feb 1, 2023
Feb 1, 2023
Jan 31, 2023
Jan 31, 2023
Jan 31, 2023